Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.

Jayson P Jessop¹, Joshua Russell¹, Adriana DeJesus¹, Chandni Bardolia¹, Abeer Hanna², Jacques Turgeon^3,4, Veronique Michaud^4,3, Nishita S Amin¹

¹Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, NJ, USA.

²Program of All-Inclusive Care for the Elderly (PACE), VieCare Beaver, Pittsburgh, PA, USA.

³Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.

⁴Precision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, Orlando, FL, USA.

PubMed PMC DOI PDF

Abstract

BACKGROUND Comorbidities and polypharmacy are difficult to manage, as polypharmacy hinders identification and prevention of medication-related problems. Risk for adverse drug events (ADEs) can be minimized through pharmacogenomic (PGx) testing and related therapeutic adjustments. CASE REPORT A 70-year-old woman with comorbidities and medications enrolled in the Program of All-inclusive Care for th…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.